h***l
发帖数: 244 | 1 07:42 AM Eastern Daylight Time, 04/19/2010 (MidnightTrader) — Sunesis
Pharmaceuticals (SNSS) announced that data from three Phase 2 clinical
trials of voreloxin, the company’s lead drug candidate, have been accepted
for presentation at the 2010 American Society of Clinical Oncology (ASCO)
Annual Meeting, which is being held June 4-8 in Chicago, Illinois.
The presentations include an oral presentation of final data from the
company’s Phase 2 trial of voreloxin in ovarian cancer, as well as poster... 阅读全帖 |
|
